Providing for consideration of the bill (H.R. 376) to amend title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate fair prices for Medicare prescription drugs on behalf of Medicare beneficiaries.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
66pct
13d open
vs 1,110 other HRES bills in the 109th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2005 · year_end · Medicare/Medicaid
Medicare Prescription Drug Savings and Choice Act (HR752) Medicare Prescription Drug Improvement Act (HR1626) Prescription Drug Price Fairness Act (HR2200) Preserving Medicare for All Act (HR2487) Medicare Prescription Drug Price Negotiation (HR 2685) Rescinds current MMA exlusion of benzodiazepines from coverage (HR3151) Allows HHS negotiation with manufacturers regarding drug price (HRes 267/S183) Meeting Our Responsibility to Medicare Beneficiaries Act (S123) Medicare Enhancements for Needed Drugs (S239) Medicare Prescription Drug Savings and Choice Act (S345/S873) Medicare Prescription Drug Price Reduction Act (S445) Medicare Value Purchasing Act (S1356) Budget Resolutions re: Medicare/Medicaid (S.Con.Res. 18/H. Con.Res.95) Labor/HHS Appropriations (HR3010) Medicare's Equitable Drugs for Seniors Act (HR376) Prescription Drug Affordability Act (HR563)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE